I'd doubt whether OMH would be interested, they have two other Mn ore projects in WA that they partner with including BYH.
The first time that I have to agree to this user.
OMH already owns a higher percentage (I think it's currently 49%) of an Mn joint venture in Bryah Resources (ASX: BYH), which also has a first-class manganese resource - I also own a stake in BYH!
In this respect, I don't see any takeover fantasy from OMH here.
The scoping study for the battery manganese will then be carried out by E25 in about 2 weeks. Due to the small loss of confidence in the most recently published figures, I personally do not expect a fireworks display, but it will provide a solid foundation to justify higher prices. The fantasy here is certainly still with a possible purchase contract with a large battery manufacturer or car manufacturer - in this case there will certainly be a revaluation of E25 and prices of 4-6 AUD!
The negative news is, in my opinion, priced into the current price of E25. Unless there is a significant slump on **promotion blocked** (endless issue of Corona or war in Ukraine), the price of manganese falls sharply or the traffic of ships collapses, I don't see any significantly lower prices here - a loss should also be for the next quarter be included in the current course.
I tend to see rising prices in the next few months: positive news (scoping study, repair / discontinuation of the system, nameplate production at the end of 2021 / beginning of 2022, improved logistics and lowering costs) are no longer included in the current price and therefore ensure a corresponding imagination in the next month.
- Forums
- ASX - By Stock
- E25
- Ann: AGM Presentation
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: AGM Presentation, page-46
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online